Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells - Implication of the tumor suppressor genes for gene therapy

Journal of Neuro-Oncology

Volumn 19, Issue 3, 1994, Pages 259-268

  Asai, Akio ^a,b   Miyagi, Yohei ^a,c   Sugiyama, Akinori ^a   Gamanuma, Michiko ^a   Hong, Seok Il ^a,d   Takamoto, Shigeru ^e   Nomura, Kazuhiro ^f   Matsutani, Masao ^g   Takakura, Kintomo ^h   Kuchino, Yoshiyuki ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d Korea Cancer Center Hospital   (South Korea)

^e TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g SAITAMA MEDICAL UNIVERSITY   (Japan)

^h TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

cell cycle; gene transfection; p53; s myc gene; tumor suppressor gene

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL CYCLE; CELL PROLIFERATION; CLONOGENIC ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN CELL; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; POINT MUTATION; POLYMERASE CHAIN REACTION; RAT; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMAL; BASE SEQUENCE; BRAIN NEOPLASMS; CELL CYCLE; GENE AMPLIFICATION; GENE EXPRESSION; GENES, MYC; GENES, P53; GLIOMA; HUMAN; MOLECULAR SEQUENCE DATA; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN P53; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0028111150     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/BF01053280     Document Type: Article

References (36)

1. Genetic alterations in glioma and medulloblastoma
2. Genetic alterations during colorectal tumor development
3. p53: A frequent target for genetic abnormalities in lung cancer
4. Mutations in the p53 gene occur in diverse human tumor types
5. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer
6. The p53 tumour suppressor gene
7. p53 mutations in human cancers
8. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
9. p53 mutations in nonastrocytic human brain tumors
10. Clonal expansion of p53 mutant cells is associated with brain tumour progression
11. Allelotype of human malignant astrocytoma
12. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency
13. Isolation and characterization of s-myc, a member of the rat myc gene family
14. Point mutation of the neu gene in rat neural tumor RT4-AC cells: Suppression of tumorigenicity by s-Myc
15. Isolation of the rat s-myc gene having tumor suppressing activity
16. Human p53 cullular tumor antigen: cDNA sequence and expression in COS cells
17. Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein
18. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wildtype p53
19. Characterization of a 54k Dalton cullular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
20. T antigen is bound to a host protein in SV40-tranformed cells
21. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53
22. Characterization of the human p53 gene
23. The p53 proto-oncogene can act as a suppressor of transformation
24. p53, guardian of the genome
25. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
26. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
27. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia
28. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
29. When the products of oncogenes and anti-oncogenes meet
30. Genetic mechanisms of tumor suppression by the human p53 gene
31. c-Myc oncoprotein function
32. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc
33. Myc and Max associate in vivo
34. Human gene therapy
35. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors